Compounds > trypan blue
Page last updated: 2024-08-17

trypan blue and Carcinoma, Transitional Cell

trypan blue has been researched along with Carcinoma, Transitional Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aikawa, K; Hashimoto, T; Irisawa, C; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O1
Irisawa, C; Koseki, K; Shiraiwa, Y1

Other Studies

2 other study(ies) available for trypan blue and Carcinoma, Transitional Cell

ArticleYear
[Clinical results of prophylactic intravesical chemotherapy on superficial bladder cancer using the dye exclusion assay].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1992, Volume: 83, Issue:11

    Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Screening Assays, Antitumor; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Premedication; Trypan Blue; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms

1992
[Chemosensitivity test on superficial urinary bladder cancer using the dye exclusion assay--model of intravesical chemotherapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1991, Volume: 82, Issue:2

    Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Drug Screening Assays, Antitumor; Mice; Mitomycin; Mitomycins; Neoplasm Transplantation; Trypan Blue; Urinary Bladder Neoplasms; Verapamil

1991